000705.SZ
Get informed when a big investor buys or sells
+ FollowOvervalued by 144.9% based on the discounted cash flow analysis.
| Market cap | $2.41 Billion |
|---|---|
| Enterprise Value | $2.31 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.07 |
| Beta | 0.3 |
| Outstanding Shares | 334,123,286 |
| P/E Ratio | -51.31 |
|---|---|
| PEG | 87.37 |
| Price to Sales | 1.38 |
| Price to Book Ratio | 1.38 |
| Enterprise Value to Revenue | 1.24 |
| Enterprise Value to EBIT | -58.84 |
| Enterprise Value to Net Income | -50 |
| Total Debt to Enterprise | 0.16 |
| Debt to Equity | 0.19 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
Based in Shaoxing, China, Zhejiang Zhenyuan Share Co., Ltd. is a pharmaceutical entity with operations extending across China and into global markets. Established in 1752, the company provides a wide array of pharmaceutical offerings. Th...